GILEAD SCIENCES, INC. Comprehensive Income
GILEAD SCIENCES, INC. (GILD) reported Comprehensive Income of -$10.48 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-06
- GILEAD SCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$10.48B, a 666.43% decline year-over-year.
- GILEAD SCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was $2.06B, a 61.57% increase year-over-year.
- GILEAD SCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was $2.19B, a 18.68% increase year-over-year.
- GILEAD SCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was $3.11B, a 151.99% increase year-over-year.
- GILEAD SCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was $8.42B, a 1341.44% increase from fiscal 2024.
- GILEAD SCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was $584.00M, a 89.74% decline from fiscal 2023.
- GILEAD SCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was $5.69B, a 26.16% increase from fiscal 2022.
- GILEAD SCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was $4.51B, a 29.16% decline from fiscal 2021.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$10.48B 10-Q · filed 2026-08-06 | -$8.42B 10-Q · filed 2026-08-06 | -$6.23B derived: sum of 3 quarters · filed 2026-08-06 | -$3.13B derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $2.06B 10-Q · filed 2026-05-07 | $4.25B derived: sum of 2 quarters · filed 2026-05-07 | $7.35B derived: sum of 3 quarters · filed 2026-05-07 | $9.20B derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $2.19B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $5.29B derived: sum of 2 quarters · filed 2026-02-24 | $7.14B derived: sum of 3 quarters · filed 2026-08-06 | $8.42B 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | $3.11B 10-Q · filed 2025-11-07 | $4.96B derived: sum of 2 quarters · filed 2026-08-06 | $6.23B 10-Q · filed 2025-11-07 | $8.07B derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $1.85B 10-Q · filed 2026-08-06 | $3.13B 10-Q · filed 2026-08-06 | $4.97B derived: sum of 3 quarters · filed 2026-08-06 | $6.20B derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $1.27B 10-Q · filed 2026-05-07 | $3.12B derived: sum of 2 quarters · filed 2026-05-07 | $4.35B derived: sum of 3 quarters · filed 2026-05-07 | $5.99B derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $1.84B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $3.08B derived: sum of 2 quarters · filed 2026-02-24 | $4.71B derived: sum of 3 quarters · filed 2026-02-24 | $584.00M 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | $1.23B 10-Q · filed 2025-11-07 | $2.87B derived: sum of 2 quarters · filed 2025-11-07 | -$1.26B 10-Q · filed 2025-11-07 | $168.00M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | $1.64B 10-Q · filed 2025-08-07 | -$2.49B 10-Q · filed 2025-08-07 | -$1.06B derived: sum of 3 quarters · filed 2026-02-24 | $1.14B derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | -$4.13B 10-Q · filed 2025-05-07 | -$2.70B derived: sum of 2 quarters · filed 2026-02-24 | -$503.00M derived: sum of 3 quarters · filed 2026-02-24 | $573.00M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | $1.43B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $3.63B derived: sum of 2 quarters · filed 2026-02-24 | $4.70B derived: sum of 3 quarters · filed 2026-02-24 | $5.69B 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | $2.20B 10-Q · filed 2024-11-12 | $3.28B derived: sum of 2 quarters · filed 2024-11-12 | $4.26B 10-Q · filed 2024-11-12 | $5.81B derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-06-30 | $1.08B 10-Q · filed 2024-08-08 | $2.06B 10-Q · filed 2024-08-08 | $3.61B derived: sum of 3 quarters · filed 2025-02-28 | $5.41B derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-03-31 | $988.00M 10-Q · filed 2024-05-08 | $2.53B derived: sum of 2 quarters · filed 2025-02-28 | $4.33B derived: sum of 3 quarters · filed 2025-02-28 | $5.49B derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | $1.54B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $3.34B derived: sum of 2 quarters · filed 2025-02-28 | $4.50B derived: sum of 3 quarters · filed 2025-02-28 | $4.51B 10-K · filed 2025-02-28 | ||||
| 2022-09-30 | $1.80B 10-Q · filed 2023-11-07 | $2.96B derived: sum of 2 quarters · filed 2023-11-07 | $2.97B 10-Q · filed 2023-11-07 | $3.36B derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2022-06-30 | $1.16B 10-Q · filed 2023-08-04 | $1.17B 10-Q · filed 2023-08-04 | $1.56B derived: sum of 3 quarters · filed 2024-02-23 | $4.18B derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2022-03-31 | $9.00M 10-Q · filed 2023-05-03 | $400.00M derived: sum of 2 quarters · filed 2024-02-23 | $3.03B derived: sum of 3 quarters · filed 2024-02-23 | $4.55B derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2021-12-31 | $391.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $3.02B derived: sum of 2 quarters · filed 2024-02-23 | $4.54B derived: sum of 3 quarters · filed 2024-02-23 | $6.37B 10-K · filed 2024-02-23 | ||||
| 2021-09-30 | $2.63B 10-Q · filed 2022-11-02 | $4.15B derived: sum of 2 quarters · filed 2022-11-02 | $5.98B 10-Q · filed 2022-11-02 | $7.45B derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-06-30 | $1.52B 10-Q · filed 2022-08-08 | $3.35B 10-Q · filed 2022-08-08 | $4.82B derived: sum of 3 quarters · filed 2023-02-22 | $5.13B derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-03-31 | $1.83B 10-Q · filed 2022-05-04 | $3.29B derived: sum of 2 quarters · filed 2023-02-22 | $3.61B derived: sum of 3 quarters · filed 2023-02-22 | $293.00M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | $1.47B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $1.78B derived: sum of 2 quarters · filed 2023-02-22 | -$1.53B derived: sum of 3 quarters · filed 2023-02-22 | -$22.00M 10-K · filed 2023-02-22 | ||||
| 2020-09-30 | $313.00M 10-Q · filed 2021-11-03 | -$3.00B derived: sum of 2 quarters · filed 2021-11-03 | -$1.49B 10-Q · filed 2021-11-03 | $1.17B derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-06-30 | -$3.31B 10-Q · filed 2021-08-05 | -$1.80B 10-Q · filed 2021-08-05 | $861.00M derived: sum of 3 quarters · filed 2022-02-23 | -$289.00M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-03-31 | $1.51B 10-Q · filed 2021-05-06 | $4.18B derived: sum of 2 quarters · filed 2022-02-23 | $3.03B derived: sum of 3 quarters · filed 2022-02-23 | $4.88B derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2019-12-31 | $2.66B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $1.51B derived: sum of 2 quarters · filed 2022-02-23 | $3.37B derived: sum of 3 quarters · filed 2022-02-23 | $5.39B 10-K · filed 2022-02-23 | ||||
| 2019-09-30 | -$1.15B 10-Q · filed 2020-11-04 | $702.00M derived: sum of 2 quarters · filed 2020-11-04 | $2.73B 10-Q · filed 2020-11-04 | $2.77B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | $1.85B 10-Q · filed 2020-08-06 | $3.88B 10-Q · filed 2020-08-06 | $3.92B derived: sum of 3 quarters · filed 2021-02-25 | $6.05B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $2.02B 10-Q · filed 2020-05-06 | $2.07B derived: sum of 2 quarters · filed 2021-02-25 | $4.20B derived: sum of 3 quarters · filed 2021-02-25 | $6.19B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | $47.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $2.18B derived: sum of 2 quarters · filed 2021-02-25 | $4.17B derived: sum of 3 quarters · filed 2021-02-25 | $5.66B 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $2.13B 10-Q · filed 2019-11-05 | $4.12B derived: sum of 2 quarters · filed 2019-11-05 | $5.62B 10-Q · filed 2019-11-05 | $1.67B derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-06-30 | $1.99B 10-Q · filed 2019-08-06 | $3.48B 10-Q · filed 2019-08-06 | -$464.00M derived: sum of 3 quarters · filed 2020-02-25 | $2.38B derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-03-31 | $1.50B 10-Q · filed 2019-05-08 | -$2.45B derived: sum of 2 quarters · filed 2020-02-25 | $394.00M derived: sum of 3 quarters · filed 2020-02-25 | $3.33B derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2017-12-31 | -$3.95B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$1.10B derived: sum of 2 quarters · filed 2020-02-25 | $1.83B derived: sum of 3 quarters · filed 2020-02-25 | $4.51B 10-K · filed 2020-02-25 | ||||
| 2017-09-30 | $2.85B 10-Q · filed 2018-11-06 | $5.78B derived: sum of 2 quarters · filed 2018-11-06 | $8.46B 10-Q · filed 2018-11-06 | $11.96B derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-06-30 | $2.93B 10-Q · filed 2018-08-06 | $5.62B 10-Q · filed 2018-08-06 | $9.11B derived: sum of 3 quarters · filed 2019-02-26 | $12.38B derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-03-31 | $2.68B 10-Q · filed 2018-05-09 | $6.18B derived: sum of 2 quarters · filed 2019-02-26 | $9.45B derived: sum of 3 quarters · filed 2019-02-26 | $13.06B derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2016-12-31 | $3.49B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $6.76B derived: sum of 2 quarters · filed 2019-02-26 | $10.38B derived: sum of 3 quarters · filed 2019-02-26 | $13.69B 10-K · filed 2019-02-26 | ||||
| 2016-09-30 | $3.27B 10-Q · filed 2017-11-07 | $6.88B derived: sum of 2 quarters · filed 2017-11-07 | $10.20B 10-Q · filed 2017-11-07 | $14.80B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $3.62B 10-Q · filed 2017-08-07 | $6.93B 10-Q · filed 2017-08-07 | $11.53B derived: sum of 3 quarters · filed 2018-02-27 | $16.05B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $3.31B 10-Q · filed 2017-05-10 | $7.92B derived: sum of 2 quarters · filed 2018-02-27 | $12.44B derived: sum of 3 quarters · filed 2018-02-27 | $16.64B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $4.60B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $9.12B derived: sum of 2 quarters · filed 2018-02-27 | $13.32B derived: sum of 3 quarters · filed 2018-02-27 | $17.89B 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $4.52B 10-Q · filed 2016-11-07 | $8.72B derived: sum of 2 quarters · filed 2016-11-07 | $13.29B 10-Q · filed 2016-11-07 | $16.90B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | $4.20B 10-Q · filed 2016-08-05 | $8.77B 10-Q · filed 2016-08-05 | $12.38B derived: sum of 3 quarters · filed 2017-02-27 | $15.33B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-31 | $4.57B 10-Q · filed 2016-05-06 | $8.18B derived: sum of 2 quarters · filed 2017-02-27 | $11.13B derived: sum of 3 quarters · filed 2017-02-27 | $14.84B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-31 | $3.61B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $6.56B derived: sum of 2 quarters · filed 2017-02-27 | $10.27B derived: sum of 3 quarters · filed 2017-02-27 | $12.53B 10-K · filed 2017-02-27 | ||||
| 2014-09-30 | $2.95B 10-Q · filed 2015-11-04 | $2.95B 10-Q · filed 2014-11-05 | $6.66B derived: sum of 2 quarters · filed 2015-11-04 | $8.91B 10-Q · filed 2015-11-04 | $8.91B 10-Q · filed 2014-11-05 | $9.62B derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-06-30 | $3.71B 10-Q · filed 2015-08-05 | $3.71B 10-Q · filed 2014-08-04 | $5.97B 10-Q · filed 2015-08-05 | $5.97B 10-Q · filed 2014-08-04 | $6.68B derived: sum of 3 quarters · filed 2016-02-24 | $7.39B derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-03-31 | $2.26B 10-Q · filed 2015-05-08 | $2.26B 10-Q · filed 2014-05-07 | $2.97B derived: sum of 2 quarters · filed 2016-02-24 | $3.68B derived: sum of 3 quarters · filed 2016-02-24 | $4.46B derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2013-12-31 | $710.06M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $1.43B derived: sum of 2 quarters · filed 2016-02-24 | $2.21B derived: sum of 3 quarters · filed 2016-02-24 | $3.00B 10-K · filed 2016-02-24 | $3.00B 10-K · filed 2014-02-25 | |||
| 2013-09-30 | $716.16M 10-Q · filed 2014-11-05 | $1.50B derived: sum of 2 quarters · filed 2014-11-05 | $2.29B 10-Q · filed 2014-11-05 | $2.98B derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-06-30 | $782.17M 10-Q · filed 2014-08-04 | $1.57B 10-Q · filed 2014-08-04 | $2.26B derived: sum of 3 quarters · filed 2015-02-25 | $2.84B derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-03-31 | $788.61M 10-Q · filed 2014-05-07 | $1.48B derived: sum of 2 quarters · filed 2015-02-25 | $2.06B derived: sum of 3 quarters · filed 2015-02-25 | $2.86B derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2012-12-31 | $688.93M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $1.27B derived: sum of 2 quarters · filed 2015-02-25 | $2.07B derived: sum of 3 quarters · filed 2015-02-25 | $2.49B 10-K · filed 2015-02-25 | $2.49B 10-K · filed 2013-02-27 | |||
| 2012-09-30 | $579.38M 10-Q · filed 2013-10-31 | $1.38B derived: sum of 2 quarters · filed 2013-10-31 | $1.80B 10-Q · filed 2013-10-31 | $2.54B derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-06-30 | $802.35M 10-Q · filed 2013-08-01 | $796.86M 10-Q · filed 2012-08-01 | $1.22B 10-Q · filed 2013-08-01 | $1.21B 10-Q · filed 2012-08-01 | $1.96B derived: sum of 3 quarters · filed 2014-02-25 | $2.82B derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2012-03-31 | $417.35M 10-Q · filed 2013-05-08 | $1.16B derived: sum of 2 quarters · filed 2014-02-25 | $2.02B derived: sum of 3 quarters · filed 2014-02-25 | $2.73B derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | $738.89M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $1.60B derived: sum of 2 quarters · filed 2014-02-25 | $2.31B derived: sum of 3 quarters · filed 2014-02-25 | $2.83B 10-K · filed 2014-02-25 | ||||
| 2011-09-30 | $858.86M 10-Q · filed 2012-11-06 | $855.28M 10-Q · filed 2011-11-04 | $1.57B derived: sum of 2 quarters · filed 2012-11-06 | $2.09B 10-Q · filed 2012-11-06 | $2.08B 10-Q · filed 2011-11-04 | $2.75B derived: sum of 4 quarters · filed 2013-02-27 | ||
| 2011-06-30 | $710.36M 10-Q · filed 2012-08-01 | $710.36M 10-Q · filed 2011-08-05 | $1.23B 10-Q · filed 2012-08-01 | $1.23B 10-Q · filed 2011-08-05 | $1.89B derived: sum of 3 quarters · filed 2013-02-27 | $2.41B derived: sum of 4 quarters · filed 2013-02-27 | ||
| 2011-03-31 | $515.21M 10-Q · filed 2011-05-09 | $1.18B derived: sum of 2 quarters · filed 2013-02-27 | $1.70B derived: sum of 3 quarters · filed 2013-02-27 | $2.51B derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2010-12-31 | $661.30M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $1.18B derived: sum of 2 quarters · filed 2013-02-27 | $2.00B derived: sum of 3 quarters · filed 2013-02-27 | $2.94B 10-K · filed 2013-02-27 | ||||
| 2010-09-30 | $520.02M 10-Q · filed 2011-11-04 | $1.34B derived: sum of 2 quarters · filed 2011-11-04 | $2.28B 10-Q · filed 2011-11-04 | $3.11B derived: sum of 4 quarters · filed 2011-11-04 | ||||
| 2010-06-30 | $815.28M 10-Q · filed 2011-08-05 | $1.76B 10-Q · filed 2011-08-05 | $2.59B derived: sum of 3 quarters · filed 2011-08-05 | $3.20B derived: sum of 4 quarters · filed 2011-08-05 | ||||
| 2010-03-31 | $941.33M 10-Q · filed 2011-05-09 | $1.77B derived: sum of 2 quarters · filed 2011-05-09 | $2.38B derived: sum of 3 quarters · filed 2011-05-09 | $2.86B derived: sum of 4 quarters · filed 2011-05-09 | ||||
| 2009-12-31 | $832.83M derived: 10-K 12 month − 10-Q 9 month · filed 2010-03-01 | $1.44B derived: sum of 2 quarters · filed 2010-11-08 | $1.92B derived: sum of 3 quarters · filed 2010-11-08 | $2.58B 10-K · filed 2010-03-01 | ||||
| 2009-09-30 | $607.99M 10-Q · filed 2010-11-08 | $1.09B derived: sum of 2 quarters · filed 2010-11-08 | $1.75B 10-Q · filed 2010-11-08 | |||||
| 2009-06-30 | $480.79M 10-Q · filed 2010-08-09 | $1.14B 10-Q · filed 2010-08-09 | ||||||
| 2008-12-31 | $2.02B 10-K · filed 2010-03-01 | |||||||
| 2007-12-31 | $1.57B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |